跳至主要内容
临床试验/NL-OMON44292
NL-OMON44292已完成不适用

Innovative MRI techniques to improve treatment stratification of patients with Esophageal cancer: an optimization and pilot study - IMPROVE

Academisch Medisch Centrum0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Volunteers:
  • Written informed consent.;Patients:
  • Patients with biopsy proven esophageal cancer (squamous cell carcinoma or adenocarcinoma).
  • Suspected nodal involvement on EUS or CT at diagnosis.
  • WHO-performance score 0-2.
  • Scheduled for surgery.
  • Written informed consent.

排除标准

  • Any psychological, familial, sociological or geographical condition potentially hampering adequate informed consent or compliance with the study protocol.
  • Contra-indications for MR scanning, including patients with a pacemaker, cochlear implant or neurostimulator; patients with non-MR compatible metallic implants in their eye, spine, thorax or abdomen; or a non-MR compatible aneurysm clip in their brain; patients with severe claustrophobia.
  • Active inflammatory diseases
  • History of anaphylaxis or other hypersensitivity reactions
  • History of iron overload
  • History of abnormal liver function, or elevated liver enzymes (ALAT, ASAT > 3 times upper limit of normal)
  • Elevated Serum Transferrin Saturation (TSAT) (>50%) or hemoglobin (>10.5mmol/L)
  • Deminished kidney function (eGFR<60)

研究者

相似试验